FNY Managed Accounts’s Amgen AMGN Stock Holding History

FNY Managed Accounts’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-30	Closed	-$75	–	427
2016 Q2	$75	Buy	+30	New	+$4.66K	﹤0.01%	285

Other funds holding AMGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

FNY Managed Accounts's AMGN Position: Q2 2017 in Review

FNY Managed Accounts sold out of Amgen (AMGN) in Q2 2017, closing a stake of 1,015 shares — an estimated $166K sold.

FNY Managed Accounts first reported a position in AMGN in Q3 2016 and held it in 2 quarters. The position peaked at $166K in Q1 2017. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

FNY Managed Accounts reported no remaining Amgen position as of Q2 2017 after selling out during the quarter.
FNY Managed Accounts sold 1,015 Amgen shares in Q2 2017, an estimated $166K.
FNY Managed Accounts first reported a position in Amgen in Q3 2016 and held it in 2 quarters.
FNY Managed Accounts's Amgen position peaked at $166K in Q1 2017.
1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on FNY Managed Accounts's 13F filing for Q2 2017, filed 10 Aug 2017.